Therapeutic potential or potentially irreversible harm?

Psychedelics, in medical terms, is an inexact category of drugs that affect perceptions and cognition. Their proponents say 1960s-era associations have undermined exciting research in the field of neuroscience. Psychedelics should be made much more widely available, they contend, to treat a range of mental and emotional issues, as well as to ascertain a more profound sense of ourselves. People should also be empowered to make their own decisions in its use. Not so fast, say opponents. These are powerful substances. And society does not know enough about the broader consequences of greatly increasing access. Cautionary tales should be heeded. Either way, like cannabis, the movement for wider use is growing. So… here’s our debate: should society legalize psychedelics?

Arguing “Yes” is Rick Doblin, Founder & Executive Director, Multidisciplinary Association for Psychedelic Studies, and Bia Labate, Anthropologist & Drug Policy Expert.

Arguing “No” is Jeffrey Lieberman, Professor & Chair, Department of Psychiatry, Columbia University, and Kevin Sabet, President & CEO, Smart Approaches to Marijuana.

Available: Content Depot & PRX Length: One hour Cost: FREE